Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies

Gliomas, and particularly glioblastoma (GBM), remain among the most lethal primary brain tumors, with outcomes constrained by extensive intra tumor heterogeneity, a profoundly immunosuppressive tumor microenvironment (TME), and the restrictive nature of the blood–brain barrier (BBB). Although immuno...

Descripció completa

Dades bibliogràfiques

Autors principals:	Abdullah Jabri, Abdulaziz Mhannayeh, Bader Taftafa, Mohamed Alsharif, Dania Sibai, Raghad Alsharif, Tasnim Abbad, Abdulrahman Elsalti, Zara Ahmed, Jahan Salma, Mohammed Imran Khan, Ahmed Yaqinuddin
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	glioblastoma glioma immunotherapy tumor microenvironment immune checkpoint inhibitors
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1690464/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!